WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome : a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)
We evaluated the impact of World Health Organization (WHO) classification and WHO classification-based Prognostic Scoring System (WPSS) on the outcome of patients with myelodysplastic syndrome (MDS) who underwent allogeneic stem cell transplantation (allo-SCT) between 1990 and 2006. Five-year overall survival (OS) was 80% in refractory anemias, 57% in refractory cytopenias, 51% in refractory anemia with excess blasts 1 (RAEB-1), 28% in RAEB-2, and 25% in acute leukemia from MDS (P = .001). Five-year probability of relapse was 9%, 22%, 24%, 56%, and 53%, respectively (P < .001). Five-year transplant-related mortality (TRM) was 14%, 39%, 38%, 34%, and 44%, respectively (P = .24). In multivariate analysis, WHO classification showed a significant effect on OS (P = .017) and probability of relapse (P = .01); transfusion dependency was associated with a reduced OS (P = .01) and increased TRM (P = .037), whereas WPSS showed a prognostic significance on both OS (P = .001) and probability of relapse (P < .001). In patients without excess blasts, multilineage dysplasia and transfusion dependency affected OS (P = .001 and P = .009, respectively), and were associated with an increased TRM (P = .013 and P = .031, respectively). In these patients, WPSS identified 2 groups with different OS and TRM. These data suggest that WHO classification and WPSS have a relevant prognostic value in posttransplantation outcome of MDS patients.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2008 |
---|---|
Erschienen: |
2008 |
Enthalten in: |
Zur Gesamtaufnahme - volume:112 |
---|---|
Enthalten in: |
Blood - 112(2008), 3 vom: 01. Aug., Seite 895-902 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Alessandrino, Emilio Paolo [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 05.09.2008 Date Revised 06.02.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1182/blood-2008-03-143735 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM179735063 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM179735063 | ||
003 | DE-627 | ||
005 | 20231223154258.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231223s2008 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1182/blood-2008-03-143735 |2 doi | |
028 | 5 | 2 | |a pubmed24n0599.xml |
035 | |a (DE-627)NLM179735063 | ||
035 | |a (NLM)18497321 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Alessandrino, Emilio Paolo |e verfasserin |4 aut | |
245 | 1 | 0 | |a WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome |b a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO) |
264 | 1 | |c 2008 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 05.09.2008 | ||
500 | |a Date Revised 06.02.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a We evaluated the impact of World Health Organization (WHO) classification and WHO classification-based Prognostic Scoring System (WPSS) on the outcome of patients with myelodysplastic syndrome (MDS) who underwent allogeneic stem cell transplantation (allo-SCT) between 1990 and 2006. Five-year overall survival (OS) was 80% in refractory anemias, 57% in refractory cytopenias, 51% in refractory anemia with excess blasts 1 (RAEB-1), 28% in RAEB-2, and 25% in acute leukemia from MDS (P = .001). Five-year probability of relapse was 9%, 22%, 24%, 56%, and 53%, respectively (P < .001). Five-year transplant-related mortality (TRM) was 14%, 39%, 38%, 34%, and 44%, respectively (P = .24). In multivariate analysis, WHO classification showed a significant effect on OS (P = .017) and probability of relapse (P = .01); transfusion dependency was associated with a reduced OS (P = .01) and increased TRM (P = .037), whereas WPSS showed a prognostic significance on both OS (P = .001) and probability of relapse (P < .001). In patients without excess blasts, multilineage dysplasia and transfusion dependency affected OS (P = .001 and P = .009, respectively), and were associated with an increased TRM (P = .013 and P = .031, respectively). In these patients, WPSS identified 2 groups with different OS and TRM. These data suggest that WHO classification and WPSS have a relevant prognostic value in posttransplantation outcome of MDS patients | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
700 | 1 | |a Della Porta, Matteo Giovanni |e verfasserin |4 aut | |
700 | 1 | |a Bacigalupo, Andrea |e verfasserin |4 aut | |
700 | 1 | |a Van Lint, Maria Teresa |e verfasserin |4 aut | |
700 | 1 | |a Falda, Michele |e verfasserin |4 aut | |
700 | 1 | |a Onida, Francesco |e verfasserin |4 aut | |
700 | 1 | |a Bernardi, Massimo |e verfasserin |4 aut | |
700 | 1 | |a Iori, Anna Paola |e verfasserin |4 aut | |
700 | 1 | |a Rambaldi, Alessandro |e verfasserin |4 aut | |
700 | 1 | |a Cerretti, Raffaella |e verfasserin |4 aut | |
700 | 1 | |a Marenco, Paola |e verfasserin |4 aut | |
700 | 1 | |a Pioltelli, Pietro |e verfasserin |4 aut | |
700 | 1 | |a Malcovati, Luca |e verfasserin |4 aut | |
700 | 1 | |a Pascutto, Cristiana |e verfasserin |4 aut | |
700 | 1 | |a Oneto, Rosi |e verfasserin |4 aut | |
700 | 1 | |a Fanin, Renato |e verfasserin |4 aut | |
700 | 1 | |a Bosi, Alberto |e verfasserin |4 aut | |
700 | 0 | |a Gruppo Italiano Trapianto di Midollo Osseo (GITMO) |e verfasserin |4 aut | |
700 | 1 | |a Levis, A |e investigator |4 oth | |
700 | 1 | |a Rambaldi, A |e investigator |4 oth | |
700 | 1 | |a Bandini, G |e investigator |4 oth | |
700 | 1 | |a Casini, M |e investigator |4 oth | |
700 | 1 | |a Rossi, G |e investigator |4 oth | |
700 | 1 | |a Angelucci, E |e investigator |4 oth | |
700 | 1 | |a Baronciani, D |e investigator |4 oth | |
700 | 1 | |a La Nasa, G |e investigator |4 oth | |
700 | 1 | |a Milone, G |e investigator |4 oth | |
700 | 1 | |a Mordini, N |e investigator |4 oth | |
700 | 1 | |a Guidi, S |e investigator |4 oth | |
700 | 1 | |a Bosi, A |e investigator |4 oth | |
700 | 1 | |a Bacigalupo, A |e investigator |4 oth | |
700 | 1 | |a Van Lint, M T |e investigator |4 oth | |
700 | 1 | |a Corradini, P |e investigator |4 oth | |
700 | 1 | |a Milani, R |e investigator |4 oth | |
700 | 1 | |a Morra, E |e investigator |4 oth | |
700 | 1 | |a Marenco, P |e investigator |4 oth | |
700 | 1 | |a Lambretenghi Deliliers, G |e investigator |4 oth | |
700 | 1 | |a Onida, F |e investigator |4 oth | |
700 | 1 | |a Ciceri, F |e investigator |4 oth | |
700 | 1 | |a Bernardi, M |e investigator |4 oth | |
700 | 1 | |a Castagna, L |e investigator |4 oth | |
700 | 1 | |a Narni, F |e investigator |4 oth | |
700 | 1 | |a Pioltelli, P |e investigator |4 oth | |
700 | 1 | |a Selleri, C |e investigator |4 oth | |
700 | 1 | |a Scimè, R |e investigator |4 oth | |
700 | 1 | |a Iannitto, E |e investigator |4 oth | |
700 | 1 | |a Musso, M |e investigator |4 oth | |
700 | 1 | |a Alessandrino, E P |e investigator |4 oth | |
700 | 1 | |a Locatelli, F |e investigator |4 oth | |
700 | 1 | |a Martelli, F |e investigator |4 oth | |
700 | 1 | |a Visani, G |e investigator |4 oth | |
700 | 1 | |a Di Bartolomeo, P |e investigator |4 oth | |
700 | 1 | |a Cavanna, L |e investigator |4 oth | |
700 | 1 | |a Papineschi, F |e investigator |4 oth | |
700 | 1 | |a Messina, G |e investigator |4 oth | |
700 | 1 | |a Gugliotta, L |e investigator |4 oth | |
700 | 1 | |a Iori, A P |e investigator |4 oth | |
700 | 1 | |a Foà, R |e investigator |4 oth | |
700 | 1 | |a Locasciulli, A |e investigator |4 oth | |
700 | 1 | |a Majolino, I |e investigator |4 oth | |
700 | 1 | |a Chiusolo, P |e investigator |4 oth | |
700 | 1 | |a Leone, G |e investigator |4 oth | |
700 | 1 | |a Arcese, W |e investigator |4 oth | |
700 | 1 | |a Cerretti, R |e investigator |4 oth | |
700 | 1 | |a Carella, A M |e investigator |4 oth | |
700 | 1 | |a Cascavilla, N |e investigator |4 oth | |
700 | 1 | |a Mazza, P |e investigator |4 oth | |
700 | 1 | |a Falda, M |e investigator |4 oth | |
700 | 1 | |a Bruno, B |e investigator |4 oth | |
700 | 1 | |a Boccadoro, M |e investigator |4 oth | |
700 | 1 | |a Fanin, R |e investigator |4 oth | |
700 | 1 | |a Cerno, M |e investigator |4 oth | |
700 | 1 | |a Raimondi, R |e investigator |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Blood |d 1946 |g 112(2008), 3 vom: 01. Aug., Seite 895-902 |w (DE-627)NLM000014761 |x 1528-0020 |7 nnns |
773 | 1 | 8 | |g volume:112 |g year:2008 |g number:3 |g day:01 |g month:08 |g pages:895-902 |
856 | 4 | 0 | |u http://dx.doi.org/10.1182/blood-2008-03-143735 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 112 |j 2008 |e 3 |b 01 |c 08 |h 895-902 |